TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
planned
Official procurement procedure

NHS National Framework for Trastuzumab 600mg Subcutaneous Injection

Published value
£85,800,000
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Framework for Trastuzumab 600mg Subcutaneous Injection". Published status: planned. Published value: £85,800,000. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
planned
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)£85,800,000
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
22.8Bids / Report
7.7% of reports have one bid
Supplier ConcentrationModerate Concentration
Anna FreudTop vendor: 29.6% of attributable value
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 859 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
Supplier NameHistoric AwardsAttributable GBP Value
Anna Freud1 win£5,862,540
Anglia Ruskin University1 win£4,809,159
NHS Shared Business Services Limited1 win£4,393,727
Pearson Professional Assessments Limited1 win£4,374,320
Timewise Foundation CIC1 win£166,667
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statusplanned
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published5 Aug 2026, 12:07 BST
Last source update5 Aug 2026, 12:07 BST
Recurring procurementNot published
ClassificationPharmaceutical products
OCIDocds-h6vhtk-06c2f7
What is being bought
Project title: NHS National Framework for Trastuzumab 600mg Subcutaneous Injection Offer reference number: CM/TNS/26/5762 Period of framework: 1 June 2027 to 31 August 2028 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
What changed
From the official release history
  1. Published value updated to £85,800,000
    5 Aug 2026, 12:07 BST
  2. Official notice release published
    5 Aug 2026, 12:07 BST
  3. Published value updated to £79,200,000
    3 Jul 2026, 09:10 BST
  4. Status changed to planned
    3 Jul 2026, 09:10 BST
  5. Official notice release published
    3 Jul 2026, 09:10 BST
  6. Buyer information updated
    3 Jul 2026, 09:10 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    planned
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Pipeline notice
    5 Aug 2026, 12:07 BST
  2. Procedure published
    5 Aug 2026, 12:07 BST
  3. engagement
    19 Aug 2026, 23:59 BST · scheduled
    NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecule(s) that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework.
Commercial outcome and competition
AwardsNo award published
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

NHS England

Contracting authority GB-PPON-PDPT-3135-BWWY
View buyer profile
  • NHS England
    buyer

    GB-PPON: PDPT-3135-BWWY
    Wellington House, 133-135 Waterloo Rd, London, UKI45, SE1 8UG, GB
Documents (1)
Official links; attachments are not copied
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleNot published